Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-06-16

FDA Approved: ALPRAZOLAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Alprazolam from Hikma Pharmaceuticals USA Inc. (generic alprazolam).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alprazolam (alprazolam)

Snippet

SUPPL AP for ALPRAZOLAM (ALPRAZOLAM)